Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
Nuance Biotech Inc logo — Creating Value Through China's Specialty Pharmaceuticals Mar...

Nuance Biotech Inc

Creating Value Through China's Specialty Pharmaceuticals Market

Founded 2014 China Shenzhen, China 8 employees Series D Total: $211.00M Biopharma, Biotechnology +1

General Information

Company Name Nuance Biotech Inc
Founded Year 2014
Location China Shenzhen, China
Employees 8
Industries Biopharma, Biotechnology, Pharmaceutical
Funding Stage Series D
Social

BounceWatch is an independent company data service, not affiliated with Nuance Biotech Inc. To contact Nuance Biotech Inc, visit nuancebiotech.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Nuance Biotech Inc compare?

A PDF of Nuance Biotech Inc and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Nuance Biotech Inc soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Nuance Biotech Inc

Nuance Biotech Inc is a China-based biotech company that has been making strides in the specialty pharmaceuticals market since its founding in 2014. The company's slogan, "Creating Value Through China's Specialty Pharmaceuticals Market," reflects their commitment to addressing unmet medical needs in the region. Nuance Biotech Inc stands out for its efficient clinical development platform and its unique approach to leveraging China and South Africa for clinical development, allowing for testing in Asian, Caucasian, and African subsets. Their strategic advantage lies in their access to leading international academic institutions and researchers, which undoubtedly contributes to the company's innovative model. The team's experience in global and China-based clinical trials has been instrumental in their success, particularly in study design and placement of studies in leading Chinese and South African drug development sites. The recent Series D investment of $181.00M in December 2020, provided by notable investors including HBM Healthcare Investments, Matrix Partners China, RTW Investments, C-Bridge Capital, GT Fund, and Beijing Konruns Pharmaceutical, demonstrates investor confidence in Nuance Biotech Inc's vision and potential. The company's focus on targeting disease areas with high unmet medical needs and affordability challenges positions them as a key player in addressing healthcare gaps in the Chinese market.

Business keywords: Biotech Company, Clinical Development, Innovation, Global Clinical Trials, Medical Research, Drug Development, Specialty Pharmaceuticals, China Market, South Africa, Unmet Medical Needs, Affordability Challenges, Academic Partnerships, Clinical Trial Design, Research Translation, Multinational Team

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Series D $181.00M 6
HBM Healthcare Investments Matrix Partners China RTW Investments
HBM Healthcare Investments, Matrix Partners China +4
07 Dec 2020
Series C $2.00M 1
HBM Healthcare Investments
HBM Healthcare Investments
22 Mar 2019
Series B $20.00M 1
C-Bridge Capital
C-Bridge Capital
28 Jun 2018
Series A $8.00M 1
Matrix Partners China
Matrix Partners China
01 May 2017

Nuance Biotech Inc Alternatives & Competitors

View All Alternatives
Nuance Biotech Inc vs
Asieris Pharmaceuticals
Asieris Pharmaceuticals United States

We strive for healthy and dignified lives!

Series D
60 employees
Biotechnology, Health Care
Nuance Biotech Inc vs
IXALTIS SA
IXALTIS SA France

DEVELOPING INNOVATIVE TREATMENTS FOR GENITOURINARY TRACT DISORDERS

Venture round
2 employees
Biopharma, Biotechnology
Nuance Biotech Inc vs
Sinogen Biopharma
Sinogen Biopharma

Pioneering the path for Chinese biotech to reach the U.S. pharmaceutical landscape, fostering the de...

Series B
Biopharma, Biotechnology
View all alternatives

FAQ About Nuance Biotech Inc

Creating Value Through China's Specialty Pharmaceuticals Market
Nuance Biotech Inc was founded in 2014.
Nuance Biotech Inc is headquartered in Shenzhen, China.
Nuance Biotech Inc operates in Biopharma, Biotechnology and Pharmaceutical. Its work centres on Biotech Company, Clinical Development, Innovation and Global Clinical Trials.
Nuance Biotech Inc has approximately 8 employees.
Nuance Biotech Inc has completed 4 funding rounds, raising a total of $211.00M. The latest funding stage is Series D.
Top alternatives and competitors to Nuance Biotech Inc include Asieris Pharmaceuticals, IXALTIS SA, Sinogen Biopharma, Nevakar Inc., BlossomHill Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Nuance Biotech Inc and Asieris Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Nuance Biotech Inc, https://bouncewatch.com/company/nuance-biotech-inc, updated 11 September 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout